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ABSTRACT
The ability of only a subset of Vibrio parahaemolyticus strains to cause human infection under cores the need for an
analytical method that can effectively differentiate between pathogenic strains and tho e that do not cau e disease. We tested
the fea ibility of a ti sue culture-based as ay to determine whether clinical isolates could be differentiated from nonclinical
i elates based on relative isolate cytopathogenicity. To screen for cytotoxic capability, we mea ured relative extracellular lactate
dehydrogenase as an indicator of host cell damage in five different mammalian cell lines in the presence of V, parahaemolyticus.
Isolate originating from clinical sources exhibited 15.5 to 59.3% relative cytotoxicity, whereas those originating from food
source exhibited 4.4 to 54.9%reJative cytotoxicity. In the presence of 1.2 X 106 cells, cytotoxicity was 1.6- to 3.5-fold
higher (P < 0.05) for clinical isolates than for nonclinical isolates in L2, Henle 407, and Caco-2 cell lines. V.parahaemolyticus
serotype 03:K6 clinical i elates had 1.6- to 2.l-fold higher cytotoxicity than did the non-03:K6 clinical i olate , with signif-
icantly higher cytotoxicity in Hel,a, J774A.1, and Henle 407 cells than in L2 and Caco-2 ceUs. Because V. parahaemolyticus
often i found in oyster, the effect of the presence of an oyster matrix on assay efficacy was al 0 tested with L2 cells. The
cytotoxicity elicited by a highly cytotoxic V, parahaemolyticus isolate was not affected by the presence of oyster ti sue,
suggesting that an oyster matrix wUJ not interfere with assay sensitivity. In the present format, this as ay can detect the
pre ence of > lOS cells of a virulent V, parahaemolyticus strain in an oyster matrix.
As a natural inhabitant of estuarine marine water, Vib-
rio parahaemoiyticus i widely di tributed in in hare ma-
rine waters throughout the world. Some V. parahaemoiy-
ticus strain are capable of cau ing human illness, and a
ub et of the e trains has been implicated in outbreak of
foodborne disease. No ingle genetic determinant has been
identified as both necessary and sufficient for V. parahae-
molyticus virulence, although many factor have been pro-
posed to be involved (45). Thermostable direct hemolysin
(TDH) i one factor that ha long been con idered a major
V. parahaemolyticus virulence marker (29, 32). A V. para-
haemolyticus train bearing a 10 -of-function mutation in
the Idh gene ha attenuated virulence in the rabbit ileal loop
modeJ (32). However, loss ofTDH did not impair V. para-
haemolyticus virulence in all model system (9, 11), indi-
cating that TDH is not the ole contributor to V. parahae-
molyticus pathogenicity. A TDH-related hemolysin (TRH)
also ha been Jinked to V. parahaemolyticus ga troenteritis
(16, 37, 38). However, V. parahaemoiyticus strains lacking
TDH have been associated with foodborne disease illnesses
(10), and some clinical isolates posse neither tdh nor trh
(23, 26), Other putative factors associated with V. para-
haemolyticus pathogenesis include urea hydrolysis, the pro-
duction of vibrioferrin, and the presence of a type III e-
cretion system (14, 24, 44). Currently, standard methods
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for isolation and differentiation of V. parahaemolyticus dic-
tate that isolates determined to be tdh po itive by PCR or
colony hybridization (40) are potential human pathogen.
However, these conventional detection strategie that pe-
cifically detect tdh alone may fail to recognize potentially
virulent tdh-negative V. parahaemolyticus strain.
Because V. parahaemolyticu trains can exchange ge-
netic material (24) and hence genetic marker (1, 33), we
hypothesized that measurement of V. parahaemolyticus vir-
ulence-as ociated characteri tic i a more reliable and ro-
bu t approach for detection of pathogenic V. parahaemo-
iyticus strain than is the pre ence or ab ence of specific
genetic markers. In support of this concept, previous work
demonstrated the potential of tis ue culture-based as ays
for detection of cytotoxic effects of pathogenic Vibrio
strains (8). For example, V. parahaemolyticus serotype 03:
K6 strain have a clearly detectable cytopathogenic phe-
notype in human epithelial HeLa cell (47).
A cytotoxicity assay was developed to measure release
of lactate dehydrogenase (LDH) from mammalian cell as
an indicator of cell damage in the presence of V. parahae-
molyticus. The objectives of this tudy were to (i) quantify
the relative cytotoxicity of various V. parahaemoiyticus iso-
lates from food or clinical ource in multiple ti sue cell
lines representing different host cell types and (ii) asse
whether a ti ue cuJture-based method could be u ed to
detect the presence of pathogenic V. parahaemolyticus pres-
ent in a eafood matrix.
-
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TABLE 1. Vibrio parahaemolyticu isolates used in this study
Laboratory no. FDA idenuficanon Serotype Source Place of isolation Year of isolation rdll res-
FSL-YI-OOJ 92000713 (I) 08 Food (clam) Unknown 1992
FSL-YI-002 NY477 04:K8 Food (oy ter) New York 1977 +
FSL-Y1-003 T3980 04:K13 Clinical Japan Unknown +
FSL-Yl-004 CRAB Unknown Food Wa hington 1972
FSL-Y 1-00Sb SC-1C 01 Food (oy ter) Wa hington 1988
FSL-YI-006 M3S0A OS ood (oyster) Washington 1994
FSL- Y 1-0 LOb T-3979 05:K15 Clinical Japan Unknown +
FSL-Y i.ou- 8332924 0l:K56 Food (oyster) Gulf 1983
FSL-YI-012 48432 04:K12 Clinical Washington 1991
FSL-YI-013 47978 06:K18 Clinical Washington 1991
FSL- Y 1-0 [4b AN-5034 04:K68c Clinical Bangladesh 1996 +
FSL-YI-01S AN-16000 OI:KUFd Clinical Bangladesh 1998 +
FSL-Yl-016 TX-2103 03:K6 Clinical Texas 1998 +
FSL- Y1-0 17b NY-30M 03:K6 Clinical New York 1998 +
FSL-Yl-021b U-5474 Old 03:K6' Clinical Bangladesh 1980 +
FSL- Y 1-023b VP86 03:K6 Clinical Calcutta 1996 +
FSL- Y1-0241> VP199 03:K6 Clinical Calcutta 1997 +
FSL-Yl-025 VP208 03:K6 Clinical Calcutta 1997 +
FSL- Y 1-026b VPISS 03:K6 Clinical Calcutta 1996 +
FSL-Y1-036 FIHE 98VI-32-4 03;K6 Clinical Japan 1998 +
FSL-YI-046 BAC-98-03255 03:K6 Clinical New York Unknown +
FSL-YI-059 98- 792-807 (27) 08:K74 Food (oyster) Galve ton Bay 1998
FSL-YI-068 DI-A6-031699 04:K9 Food (oyster) Alabama Unknown +
FSL-YI-069 Dl-B 1l-031699 04:K22 Food (oy ter) Alabama Unknown
FSL-YI-073 DI-F8-031699 OII:KUTd Food (oy ter) Alabama Unknown
FSL-YI-081 DI A6-020800 0J1:K61 Food (oy ter) Alabama Unknown
a Results were compiled from a previou study (47) and from umpublished data.
b Isolates tested for CHO elongation activity.
c Strain deemed genetically similar to 03:K6 train by arbitrarily primed PCR, ribotype , and pulsed-field gel electrophoresis pattern
analyses (5, 26).
d UT, untypeable.
e 03:K6 strain isolated before 1996 that is genetically different from the 03:K6 strain i elated after 1996.
MATERIAL A D METHOD
Bacter.ial isolates. V. parahaemolyticus i elate u ed in thi
study were provided by the U.S. Food and Drug Administration
(FDA) (Table I). Serotype were determined previously by the
Center for Disease Control and Prevention. Upon receipt, all iso-
late were treaked on tryptic soy agar (Difco, Becton Dickinson,
Sparks, Md.) upplemented with 2% NaCl (TSAS) to obtain single
colonies. Isolates were tored in tryptic soy broth upplemented
with 2% NaCI (TSBS) and 20% glycerol at -80°C. Isolate were
subcultured on TSAS at lea t once before each experiment.
Tissue cell lines. V. parahaemolyticus cytotoxicity was de-
termined in human epithelial HeLa cells (ATCC CCL-2), mouse
macrophage-like J774A.I cells (ATCC TIB-67) human epithelial
Henle 407 cells (ATCC CCL-6), rat epithelial L2 cells (ATCC
CCL-149), and the human colorectal epithelial cells Caco-2
(ATCC HTB-37). The HeLa, J774A.l, Henle 407, and L2 cells
Were maintained in Dulbecco's modified Eagle's medium (Gibco
BRL, Invitrogen, Gaither burg, Md.) upplemented with 10% fetal
bOVine erum (FBS; Gibco). aco-2 cells were maintained in min-
imal es ential medium (Gibco) upplemented with 20'* FBS. The
CHO elongation factor a ay were conducted u ing Chine e ham-
ster ovary cell CHO-IC6 (ATCC CRL-1793) that were main-
tained in Hams Fl2K medium (Gibco) with 10% FBS. All tis ue
cells were incubated at 37°C with 5% CO2,
Cytotoxicity a ay. A tissue culture-based as ay was used
to measure host cell cytotoxicity induced in the pre ence of sta-
tionary-phase V. parahaemolyticus cells. A 500-/11 aliquot of V.
parahaemolyticus cell (8 X 108 to 2 X 109 CFU/ml, a deter-
mined by standard plate count in each experiment) that had been
grown overnight in TSBS with haking (250 rpm) at 37°C was
centrifuged at 17,900 X g for 3 min, and the pellet was re u
pended in 500 J.L1of pho phate-buffered saline (PBS). The resu
pen ion was diluted 10-fold in PBS, and a 15-/11aliquot (i.e., to
yield 1.5 J.LIof the undiluted u pen ion) wa used to infect con-
fluent monoJayers of tissue cells grown in 100 /11 of the appro-
priate medium in 96-well rnicrotiter plate (Fisher Scientific In-
ternational, Inc., Hampton. NH). At 2 h postinfection, cytotoxicity
wa asses ed by mea urement of relea ed ho t cell LDH using the
CytoTox 96 on-Radioactive Cytotoxicity A say (Promega Mad-
i on, Wis.). LDH oncentration wa mea ured by reading ab or-
bance at 490 nm u ing the Fu ion Univer a1 microplate analyzer
(Packard Instrument Co., Meriden, Conn.). Relative cytotoxicity
calculations were ba ed on the following formula: cytotoxicity
(%) ::; 100 X (A,ample A pomaneolls)/(AlOlUJ Aspolltaneous), where
Asample i the ab orbance of infected ti ue cells and Aspontaneou, is
the ab orbance of uninfected tissue cells. To determine Alot.1> the
maximal relea e of LDH, ti sue cell were lysed by adding 15 j.Ll
of lysis solution according to the manufacturer's instruction . The
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TABLE 2. Relative cytotoxicity in L2 cells at 2 Iipostinfection of oyster homogenate ill the presence or absence of Y. parahaernolyticu
FSL-YJ-024
Relative cytotoxicity (%)"
Dilution OH alone OH+APW Yp alone OH+Yp OH+Vp+APW
Undiluted 4.0 ::'::2.6 A 8.15 ::'::4.0 A 80.3 ::'::5.4 B 81.7 ::'::4.8 B 104.7 ::'::3.1
IMoid 3.7 ::'::3.8 A 11.9 ::'::3.8 A 67.6 :t 7.0 c 65.9 ::'::5.8 c 48.8 ::'::4.9
100-fold -2.2::':: 3.7 A 6.11 ::'::2.9 A 17.1 ::'::3.7 A 16.8 ::'::2.2 A 11.6 ::'::3.3
II Value are mean::':: tandard error of the mean. OH, initial oyster homogenate diluted in PBS; APW, enrichment in alkaline peptone
water for 6 h at room temperature; Vp, V. parahaemoiyticus FSL-Yl-024. Approximately 1.5 x 101 and 7.5 X 106 CFU of Vp were
u ed in treatments Vp alone and OH + Vp, respectively. The dilutions for OH + Vp were prepared immediately following inoculation.
For the OH+Vp+APW treatment, oyster homogenates were inoculated with -7.5 X 106 CFU of Vp followed by enrichment in APW
for 6 h at room temperature. At the end, the enrichment ample contained -1.5 X J 08 CFU/mJ. Fifteen microliters of either undiluted
(-2.3 X 106 CFU) or diluted enrichments was u ed for the LDH assay. Relative cytotoxicity for treatments OH alone, OH + APW,
Vp alone, OH+Vp were analyzed using a two-way ANOVA. Values with different letters are significantly different (P < 0.05).
tration of I% Triton X-I 00. With each cell line, each isolate was
tested in multiple independent experiments re..ulting in at least 18
replicates.
HO elongation factor assays. Culture upernatants of V.
parahaemolyticus trains were tested for CHO elongation activity
(18, 27). Approximately 103 CHO cell were grown for 24 h In
100 jJ.1of Hams Fl2K medium with 10% FBS in 96-well micro-
titer plate'. Cells were infected with 15 jJ.Jof each V. para/we-
molyticu overnight culture supernatant or with purified TDH at
concentrations ranging from 1 to 150 u.g/rnl (Sigma-Aldrich, St.
Louis, Mo.). At specific postinfection time points, the number of
elongated CHO cells in the presence of each V. parahaemolyticus
culture upernatant was scored relative to the number of nontreat-
ed cells (negative control) or of cell treated with 5 ng/ml of
cholera toxin (Sigma) (po itive control). Po itive and negative
controls were run concomitantly in all experiment. The number
of elongated cells in the pre ence of cholera toxin was defined as
l00~ in each assay. At lea t three independent experiments were
conducted for each V. parahaemolyticus isolate. Isolates that
yielded >50~ elongated CHO cell were considered po itive.
Cytotoxicity of oyster homogenates. To determine whether
the presence of oyster tissue would influence V, parahaemoiyti-
Ct/s-induced tissue culture cytotoxicity measurements, the cyto-
toxicity assays on L2 cell were conducted with a mixture of I:
10 diluted oy ter homogenates and a highly cytotoxic V. para-
haemolyticus train. Preparation of oy ter ample wa as de-
cribed previously (46). Canned oyster purcha ed from a local
grocery lore were blended and diluted with PBS to make 1:10
diluted oyster hornogenates. The e hornogenatcs were treated with
UV radiation to kill endogenous microflora and stored at -20°C
uruil u e and are referred to hereinafter a the initial diluted oy tel'
homogenate. The highly cytotoxic V, parahaemolyticus strain
was FSL-YI-024. To prepare the bacterial culture, a l-rnl aliquot
of FSL- YJ -024 that had been grown overnight (at 37°C and 250
rpm) was washed and resuspended in I ml of PBS.
We fir t tested the effect of oyster homogenate alone on L2
cell cytotoxicity. A l-ml aliquot of the initial diluted oyster ho-
mogenate wa centrifuged at 17,900 X g for 4 min, and the pellet
was re upended in 1 mJ of PBS. This suspen ion was further
diluted 10- and 100-fold with PBS. and 15 fJ-1 of the undiluted
and each diluted u pension wa u ed to infect L2 cell '. The effect
of bacterial culture alone on L2 cell cytotoxicity wa te ted as
described above, except that 15 jJ.1of V. parahaemolyeicus FSL-
YI-024 either undiluted (containing approximately 1.5 x 107
CFU) or diluted (10- or 100-fold in PBS) was used to infect L2
cell .
To prepare an oyster homogenate and bacterial culture mix-
ture, 500 jJ.I of the initial diluted oyster homogenate and 500 j.L1
of a washed overnight culture of FSL- Y 1-024 were mixed and
then centrifuged at 17,900 X g for 4 min. This undiluted mixture
contained approximately 5.0 X 108 CFUlml of FSL-YI-024. The
pellet was resu ipended with 1 rnl of PBS, and lO- and laO-fold
dilutions were prepared. For each of the undiluted and diluted
mixtures, 15 u.l wa used to infect L2 cells as de cribed above.
The undiluted infected mixture contained approximately 7.5 X
106 CFU of FSL- Y] -024.
To determine the effect of an enrichment step on assay effi-
cacy, a mixture of 500 fJ-1 of initial diluted oyster homogenate and
500 fJ-1 of bacterial culture were incubated tatically with 30 ml
of alkaline peptone water (APW) at 3rC for 6 h. Following the
enrichment incubation period, the su pension wa mixed thor-
oughly, and I rnl wa tran ferred to a 1.5-1111eppendorf tube. The
suspension wa wa .hed once and then resuspended with I rnl of
PBS, and 15 jJ.1of the undiluted and diluted (10- and lOa-fold)
enrichment samples was used to infect L2 cell. The undiluted
enrichment sample was evaluated for FSL- Y 1-024 concentration,
which was approximately 1.5 X 108 CFU/m!. Therefore, the un-
diluted infected mixture contained approximately 2.3 X 106 CFU.
As a negati ve control, the initial diluted oyster homogcnates and
APW mixture wa tested a described above but without addition
of a bacterial culture. For all treatments, each sample was run at
least in quadruplicate in three independent experiment.
Statistical analyse', The differences in cytotoxicity between
food and clinical i olate , tdh-positive and edit-negative i elate ,
and 03:K6 and non-03:K6 V. parahaemolyticus trains were an-
alyzed u ing the two- ample e test and the Mann-Whitney te t for
normally and nonnorrnally distributed data, respectively (Minitab
Inc., State College, Pa.). Differences in cytotoxicity among treat-
ments in Table 2 were analyzed by two-way analysis of variance
(ANOVA; Minitab Inc.). Differences were considered significant
at P < 0.05.
RE ULTS AND DISCUSSIO
One common strategy for identifying pathogenic bac-
terial strain i to te t for the presence of pecific gene or
protein products that are correlated with pathogenicity (i.e.,
virulence marker ). Examples of virulence marker include
inv, which encode a mammalian cell invasion factor, and
1. Food Prot., Vol. 70, o. 2
ial, which is the inva ion-associated locu . The pre ence of
inv is associated with pathogenic strain of Yer inia pseu-
dotuberculosis (12, 39) and ial is highly specific for Shi-
gella and enteroinvasive Escherichia coli (22). The reli-
ability of virulence markers for differentiation of pathogen-
ic strains i dependent on the universality of the presence
of the marker in strains capable of causing disease.
The current standard method for detection of patho-
genic V. parahaemolyticus strain i ba ed on the presence
of tdh (encoding the TDH protein) and Irh (encoding TDH-
related hemolysin) (40). Not all pathogenic V. parahae-
molyticus are positive for tdh and trh, and the ability of
vibrios to exchange genetic material, and genetic markers
(I, 33), trongly under core the need for development of
analytical tools that can mea ure the functional capability
of a pecific train to cau e di ea e. We reasoned that a
ti ue culture approach that allowed mea urement of the
relative cytopathogenicity of clinical V. parahaemolyticus
strain and of strains not a ociated with human illne
might provide such a tool. The relative cytotoxicity of V.
parahaemofyticus isolates wa examined by measuring
LDH relea e in several different ho t cell line . We al a
tested the fea ibility of u ing LDH release a a detection
method for V. parahaemoiyticus in eafood sample .
Cytopathogenicity a say and groupings of isolate.
Becau e microorgani ill interact differently with host ti
sues from different source (15, 41), we chose multiple ti
sue cell lines representing differ nt host celJ type, includ-
ing the HeLa cell line that has been used in previous tudie
on V. parahaemolyticus (28, 35, 47), to measure relative
cytotoxicity of the isolate in our V. parahaemolyticus col-
lection. Specifically, we mea ured host cell release ofLDH,
an indigenou enzyme found in human and animal cells, in
the presence of the V. parahaemotyticus cultures. The quan-
tity of LDH released i proportional to the degree of dam-
age to the host cell membrane (31) incurred by exposure
to V. parahaemolyticus.
In Vibrio cholerae and Salmonella, enterotoxigenicity
i associated with production of a factor that cau es elon-
gation of CHO cells (7, 36). Therefore, we al 0 conducted
the CHO cell elongation assay (i) to determine whether V.
parahaemolyticus possesses a CHO cell elongation factor
and if so (ii) to determine the fea ibiJity of this assay for
differentiating between pathogenic and nonpathogenic bac-
teria.
The isolates used in this rudy were cla Hied into var-
iou categories. Clinical isolates were obtained from patient
tool sample, and food i olates (i.e., nonclinical isolates)
were obtained from food amples that had not been as 0-
ciated with any clinical ca e . Isolate were also classified
by serotype into 03:K6 and non-03:K6 groups. V. para-
haemotvucus serotype 03:K6 is an emerging pathogen hy-
pothesized to have enhanced virulence relative to non-03:
K6 strains; 03:K6 trains and the closely related clonal
groups have caused a number of human disease outbreak
worldwide since 1996 (3, 4, 6, 20, 34). Because TDH ha
long been regarded a a virulence marker for V. para/we-
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FIGURE 1. Cytotoxicity (%, relative to complete chemical cell
lysis) in different cell lines at 2 h postinfection with V. parahae-
molyticu isolates. Cytotoxicity wa' measured by host LDH re-
lease. Error bars represent the standard error of the mean. Mean
cytotoxicity percentages are noted in table below each figure.
For statistical analyses, isolates were grouped: (A) food and clin-
ical isolates; (B) clinical non-03:K6 versus 03:K6 isolates; and
(C) tdh + versus tdh isolates. An asterisk indicates that the cy-
totoxicity difference between each group for a given cell line is
significantly different (P < 0.05).
molyticus (29, 32), we also compared the relative cytotox-
icity of i olates with and without tdh.
V. parahaemolyticus isolates exbibit different cyto-
toxic capabilities. When grouped by source, food and clin-
ical isolates had different cytotoxic capabilitie . For aU tis-
sue culture cell lines, the mean cytotoxicity of clinical i 0-
late was greater than that for food isolate (Fig. IA). Clin-
ical isolate exhibited 54.5, 59.6, 50.0, 36.9, and 15.5%
relative cytotoxicity in HeLa, J774.Al, L2, Henle 407, and
Caco-Z cell line, respectively, whereas, food i olates ex-
h.ibited 43.8, 54.9, 26.2 22.4, and 4.4% relative cytotox-
icity in th e respective cell line . The relative cytotoxicity
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in the L2, Henle 407, and Caco-2 cell lines. Cytotoxicity
of the V. parahaemolyticus 03:K6 and non-03:K6 i olate
also was compared. Because all 03:K6 isolates in our col-
lection were from clinical sources, only clinical non-03:K6
i olate were compared with clinical 03:K6 isolates. Cy-
totoxicity differences between the e two group were ig-
nificant in Henle 407 cells (45.0% with the 03:K6 group
vel' us 23.9% with the non-03:K6 group), HeLa cells (67.3
versus 31.4%), and J774A.I cell (68.5 versu 43.5%) (Fig.
lB). The differences in L2 cells (61,0 versu 32.5%) were
marginally significant (P < 0.10). Although tdh-positive
isolates appeared to have slightly higher cytotoxicity than
tdh-negative i olates (Fig. IC), the differences were signif-
icant only for the Caco-2 cell line.
Our findings from the LDH as ays support conclusion
from previou tudies, which suggested that the presence
of tdh alone does not fully correlate with cytotoxicity, fluid
accumulation, and other virulence measurements (9, 23,
35); therefore, tdh alone i not sufficient as a predictor for
V. parahaemotyticus pathogenicity. Our re ult further ug-
ge t that the apparent enhanced virulence of V. parahae-
molyticus 03:K6 strain could be a sociated with the en-
hanced cytotoxic effects that these cells have on host cell .
When cla ified into group by ource, clinical isolates had
higher relative cytotoxicity than did food isolates in three
ho t cell lines. In its current format, however, this LDH
assay cannot reliably discriminate between clinical and
nonclinical i olates at the strain level because the relative
cytotoxicity percentage in these two group of isolates
overlap. Nevertheless, with further development, a ti ue
culture-ba ed assay may be a useful approach for the de-
tection of pathogenic trains becau e the outcome of such
an assay will be more dependent on the ability of a train
to cau e di ease than on the pre ence or absence of one or
more specific virulence determinant ,
CHO elongation factor is not useful for evaluation
of V. parahaemolyticus pathogenicity. Although V. para-
haemolyticus i olates clearly differed in their cytotoxic ef-
fects on host cells, the organism does not appear to possess
a CHO elongation factor under the conditions tested. Nine
V. parahaemolyticus isolates (Table 1) were creened for
the presence of the CHO elongation factor, but none were
positive, Thus, the CHO elongation assay is not useful for
characterization of V, parahaemolyticus pathogenicity.
Development of a tissue culture-based assay to de-
tect cytotoxic V. parahaemolyticus. Becau e clinical iso-
lates generally were more cytotoxic than were nonclinical
i olates, we further tested the efficacy of the LDH assay as
a detection tool to screen for the pre ence of V. parahae-
molyticus strains with pathogenic potential in food sample .
Our goal with the e experiment wa to as e the ability
of our as ay to detect the presence of pathogenic V. para-
haemolyticus directly from an oyster tissue matrix. The
ability to detect potentially dangerou pathogens directly
from food samples could ignificantly reduce the analytical
time needed to make deci ions related to hazards that may
be a ociated with bacterial contamination, such as deter-
mining the afety of oy ter bed or the need to issue a
J. Food Prot., Vol. 70. o. 2
product recal!. However, food rnarrice can interfere with
analytical outcomes, For example, inhibitory sub tance
present in food can lead to false-negative results with orne
detection technologic uch as tho e involving PCRs (19),
Oyster sample were te ted becau e V. parahaemolyticus
infection have been a ociated frequently with can ump-
tion of raw or undercooked bivalve shellfi b. We selected
L2 cells for a say development because the cytotoxicity dif-
ference between clinical and nonclinical isolates was the
most pronounced with thi cell line, i.e., 6 (46.2%) of 13
clinical isolates but none of the food isolate had >60%
relative cytotoxicity. The fast-growing L2 cell line al a is
ea y to maintain. V. parahaemolyticu FSL- Y 1-024 was se-
lected for the development of the screening a say because
of it relative evere cytotoxic effects in all cell lines (data
not hown).
Approximately 5 X 108 CFU of FSL- YI-024 culture
wa used to artificially inoculate the initial diluted oyster
homogenates, and then 15 J-LIof the mixture (undiluted or
diluted 10- or 100-fold) were used to infect L2 cell either
with or without an enrichment step. Results are summarized
in Table 2, A low level of cytotoxicity wa detected in
oy tel' homogenates and APW (treatments OR alone and
OH + APW in Table 2), pre umably because of nonspecific
LDH release from the oyster samples. Thi nonspecific
LDH relea e can tituted the background level for our assay,
When L2 cell were inoculated with 1.5 X 107 CFU ofV.
parahaemolyticus FSL- Yl-024 alone, a strong response
(80.3% cytotoxicity) wa detected. A reduced response
(67.6% cytotoxicity) wa detected with to-fold diluted cul-
ture , i.e., 1.5 X 106 CFU. The cytotoxicity of the lOO-fold
diluted culture was not significantly different from the
background. Component pre ent in oy ter homogenate ,
including endogenous LDH, did not appear to affect detec-
tion of V, parahaemoiyticus; similar cytotoxicity was de-
tected for FSL- Y1-024 either with or without oy tel' ho-
mogenates (treatments OH+Vp and Vp alone),
Although the addition of an enrichment tep to a de-
tection assay increases the overall time required for a ay
completion, thi step can improve assay sensitivity. We
demon trated previously that a 6-h enrichment period wa
optimum for detecting a larger collection of V. parahae-
molyticus with a PCR method (46). Enrichment at an ap-
propriate temperature Can allow injured cells to recover and
viable-but-nonculturable (VBNC) cell to re u citate (13,
21, 25). In thi regard, an enrichment tep may be partic-
ularly useful for V. parahaemolyticu because of its ability
to enter into the VBNC tage (2, 30). Wong et aI. (43)
found that VB C cell exhibited delayed mouse lethality
and enteropathogenicity compared with log-pha e cells. In
the natural environment, V. parahaemoiyticus al 0 may be
injured or starved. Wong and Chang (42) found that a hort
incubation wa neces ary to enable starved V. parahae-
molyticus cell to reach the same cytopathogenicity as ex-
hibited by the log-pha e cells. To balance the benefits of
enrichment with the need for a rapid assay, a 6-h enrich-
ment period wa selected for the pre ent study. FSL- Yl-
024 numbers increased by 1,26 log CFU following this en-
richment. Stati tical comparison of the treatm nt with an
1. Fo d Pror., Vol. 70, o. 2
enrichment step (OH +Vp+ APW) and the other treatments
wa not conducted because bacterial cell number differed
by >0.5 log C U.
Cytotoxicity mea urements following enrichment may
not be comparable to tho e without enrichment. In this
tudy, V. parohaemolyticus cell after the 6-h enrichment
were likely in late Jog to early tationary phase in contra t
to the late tationary pha cell u ed in other treatm nt .
There i increa ing evidenc that virulen e of bacterial
pathogen u h a Listeria monocytogene (15) and Strep-
tococcus pneumoniae (17) is influenced by environmental
tr e and growth pha e. Thus, it i also pos ible that V.
parahaemolyticu cytopath genicity may be influenced by
growth phase. Further tudy will b neces. ary to asses th
effect of growth pha on V. parahaemolyticus virulence
characteri tic .
In its current format, our LDH a say can differ ntiate
clinical V. parahaemolyticus strains only at the population
level. uture a ay optimization also must tak into on id-
eration the pre nee of other microfl ra in a typical t t
matrix. Improved n itivity and pecificity will be neces-
ary for application of thi approach a a routin detection
procedure.
onventi nal detection tools designed t e rabli h the
pre ence of ne genetic determinant or phenotypi char-
acteri tic in a given i olate are likely to b of only limited
utility for det cting emerging path genic V. parahaemoly-
ticus train. In th pre ent rudy we amined the utility
of a ti ue culture-based as ay for d velopment of detecti n
method for pathogenic V. parahaemolyticu train. A a
group, clinical i olate are more cytotoxic than nonclinieal
i alate. Ba ed on LDH relea e re ult , -106 cells of cy-
totoxic V. parahaemolyticus were detect d. An ptimized
enrichment tep might further enhance the en itivity of thi
assay. Further insight into factor contributing to V. para-
haemolytieus pathogen si will enable development of new
detection method w.ith increased sen itivity and discrimi-
natory capabil itie .
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